Kristi Batchelor

November 20, 2020

ReAlta Life Sciences Featured in Norfolk Innovation Corridor, Launch of New Technology Zone

Norfolk, Virginia, known globally for its expertise in resilience and strong entrepreneurship ecosystem, is emerging as a tech hub for companies supporting products, technologies and services […]
November 16, 2020

Norfolk biotech startup studies new COVID-19 treatment, moves into new headquarters

The Virginia Pilot | November 16, 2020 https://www.pilotonline.com/inside-business/vp-ib-realta-covid-update-1109-20201116-hkwsno4uencqvbq7tjidj7alva-story.html
October 20, 2020

ReAlta Life Sciences to Hold Ceremony for Grand Opening of State-of-the-Art Headquarters in Opportunity Zone in Norfolk Virginia

Norfolk, VA, October 20, 2020 — ReAlta Life Sciences, Inc., today announced the details of a formal ribbon-cutting ceremony at their new headquarters located at 5665 Lowery Road, […]
July 28, 2020

ReAlta Life Sciences Announces U.S. FDA Clearance of First Investigational New Drug Application for RLS-0071

Phase 1 Trial for the Treatment of Patients with Acute Lung Injury Due to COVID 19 Anticipated to Begin in Third Quarter of 2020 Norfolk, VA, […]
June 29, 2020

ReAlta Life Sciences to Participate in Oppenheimer’s Private Life Sciences Company Call Series

Norfolk, VA, June 29, 2020 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive Officer, is scheduled to participate in […]
June 19, 2020

ReAlta Life Sciences To Receive a Commonwealth Research Commercialization Fund (CRCF) Grant

ReAlta Life Sciences is pleased to have received a Commonwealth Research Commercialization Fund (CRCF) grant. This award will help support the clinical development of ReAlta’s lead […]
May 28, 2020

ReAlta Life Sciences, Inc. to participate in the Virtual 2020 BIO International Convention, BIO Digital

Norfolk, VA, May 28, 2020 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming virtual BIO International Convention, BIO Digital, being held June 8 – 12, […]
April 21, 2020

ReAlta Life Sciences Closes $14 Million Series A2 Financing to Support Transition into a Clinical Organization

Proceeds to Fund Advancement of Programs Addressing Acute Lung Injury Due to COVID-19 and Severe Birth Asphyxia (HIE) Norfolk, VA, April 21, 2020 — ReAlta Life […]
April 9, 2020

ReAlta Life Sciences Strengthens Board of Directors with Election of Edward Heidt as Chair and Appointments of Dr. Jonathan Zalevsky and Christine Neikirk

Norfolk, VA, April 9, 2020 — ReAlta Life Sciences, Inc., a biotech company dedicated to harnessing the power of the immune system through its PIC1 technology […]
March 10, 2020

ReAlta Life Sciences Strengthens Board of Directors with Appointments of Industry Leaders Dr. Deborah Geraghty and Dr. Azmi Nabulsi

Norfolk, VA, March 10, 2020 — ReAlta Life Sciences, Inc., a biotechnology company dedicated to harnessing the power of the immune system to address life-threatening medical […]
Loading...